Entering text into the input field will update the search result below

Aoxing Pharmaceutical reports FQ2 results

  • Aoxing Pharmaceutical (NYSEMKT:AXN): FQ2 EPS of $0.03
  • Revenue of $8.2M (+27.5% Y/Y)
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
AXN--
Aoxing Pharmaceutical Company, Inc.